John Zhao is the Director of Process Development at Kytopen, where he leads a multi-disciplinary team advancing non-viral payload delivery technologies for cellular therapies. His oversees the development and optimization of consumables and reagents for the company’s Flowfect® platform, enabling efficient, scalable delivery of genetic material across diverse cell types.

With over a decade of experience in cell and gene therapy, John brings deep expertise spanning early-stage research, process development, andcommercial-scale manufacturing.

John earned a Master of Science in Biochemistry and Molecular Biology at the University of Louisville, Kentucky.

John will be a scientific lead for the transfection workflows and processing.